Skip to main content
BrainCited
Figure 5

Descrizione

A schematic timeline of Alzheimer's disease progression alongside potential intervention windows for antioxidant and BBB-targeting drug delivery systems is shown, emphasizing early intervention strategies.

More Figures from This Paper

Various nanoparticle-based drug delivery systems designed to cross the blood-brain barrier are depicted, including liposomes, polymeric nanoparticles, and solid lipid carriers for Alzheimer's disease therapeutics.

Figure 2

Various nanoparticle-based drug delivery systems designed to cross the blood-brain barrier are depicted, including liposomes, polymeric nanoparticles, and solid lipid carriers for Alzheimer's disease therapeutics.

diagram
Antioxidant mechanisms relevant to Alzheimer's disease neuroprotection are summarized, highlighting how reactive oxygen species contribute to neurodegeneration and how antioxidant-loaded delivery systems may counteract oxidative damage.

Figure 3

Antioxidant mechanisms relevant to Alzheimer's disease neuroprotection are summarized, highlighting how reactive oxygen species contribute to neurodegeneration and how antioxidant-loaded delivery systems may counteract oxidative damage.

diagram
A comparative overview of different blood-brain barrier crossing strategies is presented, including receptor-mediated transcytosis, adsorptive transcytosis, and focused ultrasound approaches for drug delivery.

Figure 4

A comparative overview of different blood-brain barrier crossing strategies is presented, including receptor-mediated transcytosis, adsorptive transcytosis, and focused ultrasound approaches for drug delivery.

diagram

Figure 5

Diagram
824 × 571px · 280,3 KB

Source Paper

Latest Perspectives on Alzheimer's Disease Treatment: The Role of Blood-Brain Barrier and Antioxidant-Based Drug Delivery Systems.

Molecules (Basel, Switzerland) (2024)

PMID: 39274904

DOI: 10.3390/molecules29174056

Cite This Figure

![Figure 5: A schematic timeline of Alzheimer's disease progression alongside potential intervention windows for antioxidant and BBB-targeting drug delivery systems is shown, emphasizing early intervention strategies.](https://pdfs.citedhealth.com/figures/39274904/207.png)

> Source: Bianca Sânziana Daraban et al. "Latest Perspectives on Alzheimer's Disease Treatment: The Role of Blood-Brain Ba." *Molecules (Basel, Switzerland)*, 2024. PMID: [39274904](https://pubmed.ncbi.nlm.nih.gov/39274904/)
<figure>
  <img src="https://pdfs.citedhealth.com/figures/39274904/207.png" alt="A schematic timeline of Alzheimer's disease progression alongside potential intervention windows for antioxidant and BBB-targeting drug delivery systems is shown, emphasizing early intervention strategies." />
  <figcaption>Figure 5. A schematic timeline of Alzheimer's disease progression alongside potential intervention windows for antioxidant and BBB-targeting drug delivery systems is shown, emphasizing early intervention strategies.<br>  Source: Bianca Sânziana Daraban et al. "Latest Perspectives on Alzheimer's Disease Treatment: The Role of Blood-Brain Ba." <em>Molecules (Basel, Switzerland)</em>, 2024. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/39274904/">39274904</a></figcaption>
</figure>

Evidenze correlate

B
Curcumin per Age-Related Cognitive Decline

Grado B · 10 studi

 B
Curcumin per Oxidative Stress & Neuroinflammation

Grado B · 15 studi

 C
Curcumin per Memory Loss

Grado C · 8 studi